Inhibition of Nicotinamidase Impacts Growth, Development, and Lifespan of and .

J Agric Food Chem

State Key Laboratory of Agricultural and Forestry Biosecurity, College of Plant Protection, Nanjing Agricultural University, 666 Binjiang Avenue, Jiangbei New District, Nanjing 211800, China.

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Nicotinamidase (Naam), which is essential for insect NAD synthesis but absent in mammals, represents a potential pesticide target. Virtual screening identified 1-[4-(trifluoromethyl)-3-pyridinyl]-ethanone (4-TFPE) as a potent inhibitor of (IC = 4.156 μM) and (IC = 2.855 μM) Naam. While 4-TFPE reduced pupal weight, development, and longevity in both species, it showed no lethal toxicity. Crucially, Naam expression was upregulated by nicotinamide accumulation, revealing a feedback regulation mechanism that compromises its pesticidal potential. Furthermore, Flumetnicam's neurotoxic effects were found to be Naam-independent. These findings highlight how target compensation mechanisms can undermine pesticide development focused on single metabolic enzymes, suggesting the need for multitarget strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jafc.5c08472DOI Listing

Publication Analysis

Top Keywords

inhibition nicotinamidase
4
nicotinamidase impacts
4
impacts growth
4
growth development
4
development lifespan
4
lifespan nicotinamidase
4
nicotinamidase naam
4
naam essential
4
essential insect
4
insect nad
4

Similar Publications

Inhibition of Nicotinamidase Impacts Growth, Development, and Lifespan of and .

J Agric Food Chem

September 2025

State Key Laboratory of Agricultural and Forestry Biosecurity, College of Plant Protection, Nanjing Agricultural University, 666 Binjiang Avenue, Jiangbei New District, Nanjing 211800, China.

Nicotinamidase (Naam), which is essential for insect NAD synthesis but absent in mammals, represents a potential pesticide target. Virtual screening identified 1-[4-(trifluoromethyl)-3-pyridinyl]-ethanone (4-TFPE) as a potent inhibitor of (IC = 4.156 μM) and (IC = 2.

View Article and Find Full Text PDF

Inwardly rectifying potassium (Kir) channels regulate essential physiological processes in insects and have been identified as potential targets for developing new insecticides. Flonicamid has been reported to inhibit Kir channels, disrupting the functions of salivary glands and renal tubules. However, the precise molecular target of flonicamid remains debated.

View Article and Find Full Text PDF

An insecticide target in mechanoreceptor neurons.

Sci Adv

November 2022

Ministry of Agriculture Key Laboratory of Molecular Biology of Crop Pathogens and Insects, Institute of Insect Sciences, Zhejiang University, Hangzhou 310058, China.

Hundreds of neurotoxic insecticides are currently in use. However, only a few direct targets have been identified. Here, using and the insecticide flonicamid, we identified nicotinamidase (Naam) as a previous unidentified molecular target for an insecticide.

View Article and Find Full Text PDF

Nicotinamidase as A Novel Antimalarial Target.

Biomolecules

August 2022

Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.

Inhibition of nicotinamidase could represent a potential antimalarial since parasites require nicotinic acid to successfully recycle nicotinamide to NAD, and importantly, humans lack this biosynthetic enzyme. Recently, mechanism-based inhibitors of nicotinamidase have been discovered. The most potent compound inhibits both recombinant nicotinamidase and parasites replication in infected human red blood cells (RBCs).

View Article and Find Full Text PDF

The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors.

Front Microbiol

January 2021

Division of Bioinformatics and Biochemistry, Department of Materials, Environmental Sciences and Urban Planning, Polytechnic University of Marche, Ancona, Italy.

Given the upsurge of drug-resistant tuberculosis worldwide, there is much focus on developing novel drug combinations allowing shorter treatment duration and a lower toxicity profile. Nicotinamide adenine dinucleotide (NAD) biosynthesis targeting is acknowledged as a promising strategy to combat drug-susceptible, drug-resistant, and latent tuberculosis (TB) infections. In this review, we describe the potential synergy of NAD biosynthesis inhibitors with several TB-drugs in prospective novel combination therapy.

View Article and Find Full Text PDF